1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

What's Compensation Like?

Discussion in 'Ivoclar Vivadent' started by Anonymous, Jan 6, 2012 at 5:09 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Can anyone give me any info on this for the sales position?
     

  2. Anonymous

    Anonymous Guest

    The bastards fired their reps.
     
  3. Anonymous

    Anonymous Guest

    How about in the Midwest?